$HIMS Interesting timing. Just four hours ago, Hims posted on IG a “Peptides 101” carousel, highlighting that 170+ peptides are in active clinical development and emphasizing the importance of sourcing, formulation, and quality. This does not confirm a new product launch, but with the FDA peptide meeting approaching, the timing is hard to ignore. $HIMS may be laying the groundwork for its next major category. Buckle up.
View on X ↗